The Effects of Ganciclovir and Valganciclovir Antiviral Treatments in Children with Congenital Cytomegalovirus Infection

Loading...
Thumbnail Image
Authors
Centola, Allyson
Issue Date
2016
Type
Presentation
Language
en_US
Keywords
congenital cytomegalovirus , antiviral treatments , ganciclovir , valganciclovir
Research Projects
Organizational Units
Journal Issue
Alternative Title
Abstract
Congenital cytomegalovirus (cCMV) is one of the leading causes of non-hereditary newborn hearing losses. Typically children with a hearing loss would receive amplification to help combat the loss; however, new research has shown that children who have cCMV can receive antiviral treatments in lieu of amplification. Ganciclovir and valganciclovir are the antiviral treatments that are currently being used. These antiviral treatments help eliminate the viral load in the blood and thus improve the child’s hearing loss.
Description
Senior capstone poster, Department of Communication Sciences and Disorders, SUNY Plattsburgh
Citation
Publisher
License
Journal
Volume
Issue
PubMed ID
DOI
ISSN
EISSN